The global hereditary angioedema treatment market to gain from increasing incidences of

genetic mutation. Recently Fortune Business Insights, published a report titled, “Hereditary
Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase
Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis,
Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital
Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.” As per the report, the global
hereditary angioedema treatment market was worth US$ 1883.1 Mn in 2017. The global market
is anticipated to expand at a CAGR of 16.8% and reach US$ 6533.3 Mn by the end of 2025. The
report classifies the global hereditary angioedema treatment market in various segments and
offer a comprehensive overview.

According to the report, the hereditary angioedema treatment market in North America was
valued at US$ 1752.2 Mn in 2017. The growth witnessed is attributable to high prevalence of
hereditary angioedema in the region. North America may remain dominant in the global market
through the forecast period (2018-2025) also. Presence of an established healthcare system and
increasing healthcare expenditure are a few factors anticipated to contribute the expansion of
the hereditary angioedema treatment market in North America. The report also predicts the
market in Asia Pacific to witness impressive growth. Increasing medical tourism in nations such
as China and India will create lucrative growth opportunities for the market in the region. Besides
this, increasing number of product innovations in the region backed by high presence of
hereditary angioedema drugs manufacturers will give tailwinds to growth witnessed by the
hereditary angioedema treatment market.

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hereditary-
angioedema-treatment-market-100164

C-1 Esterase Inhibitor Segment to Dominate Global Market During Forecast Period

In terms of drug class, the C-1 esterase inhibitor is the most popular drug and dominated the
global hereditary angioedema treatment market in 2017. The segment accounted for 61.3% of
the global market in 2017. The trend is unlikely to change during the forecast period 2018-2025
owing to the drug’s reliability among patients and practitioners.

Increasing awareness about the disorder and rising prevalence of the hereditary angioedema are
some factors expected to drive the global hereditary angioedema treatment market during the
forecast period. Additionally, technological developments in the hereditary angioedema
treatment devices and equipment is expected to boost the global market.
According to the U.S. Hereditary Angioedema Association, hereditary angioedema may not
necessarily occur due to prior familial history of the disease. In 25% of the cases hereditary
angioedema may arise due to spontaneous mutation of the gene called C-1 inhibitor. This is
anticipated to enable growth in the global hereditary angioedema treatment market.

On the flip side, the side effects and high cost associated with hereditary angioedema drugs and
treatment is the major factor that may restrain the global hereditary angioedema treatment
market.

Shire, CSL Behring, and Pharming Group NV to Lead the Global Market

The global hereditary angioedema treatment market is witnessing entry of new players in the
market. However, at present Pharming Group NV, Shire, and CSL Behring are together leading
the global market owing to the organization’s strong distribution network. Some of the other
companies operating in the global hereditary angioedema treatment market are BIOCRYST
PHARMACEUTICALS INC., Ionis Pharmaceuticals Inc., Attune Pharmaceuticals, Arrowhead
Pharmaceuticals Inc., and Adverum.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/hereditary-angioedema-treatment-market-
100164

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative solutions for our clients,
assisting them address challenges distinct to their businesses. Our goal is to empower our clients
with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies
achieve sustainable growth. Our team of experienced analysts and consultants use industry-
leading research tools and techniques to compile comprehensive market studies, interspersed
with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for
our clients. We therefore offer recommendations, making it easier for them to navigate through
technological and market-related changes. Our consulting services are designed to help
organizations identify hidden opportunities and understand prevailing competitive challenges.